1. Home
  2. Browse Decisions
  3. F.3d
  4. 745 F.3d
  5. 745 F.3d 216 (2014)
 

IN RE PETITION OF BOEHRINGER INGELHEIM

No. 13-3898.

745 F.3d 216 (2014)

In Re Petition of BOEHRINGER INGELHEIM PHARMACEUTICALS, INC., and BOEHRINGER INGELHEIM INTERNATIONAL GMBH, in Pradaxa (Dabigatran Etexilate) Products Liability Litigation.

United States Court of Appeals, Seventh Circuit.

Decided January 24, 2014.

Attorney(s) appearing for the Case

Dan Howe Ball , Attorney, Bryan Cave LLP, St. Louis, MO, Beth Rose , Attorney, Sills, Cummis, Zuckerman, Radin, Tischman, Epstein & Gross, Newark, NJ, for Boehringer Ingelheim Pharmaceuticals, Inc., and Boehringer Ingelheim International GMBH.

Roger Clark Denton , Attorney, Schilchter, Bogard & Denton, St. Louis, MO, Mark Robert Niemeyer , Attorney, Onder, Shelton, O'leary & Peterson, LLC, Webster Groves, MO, for Pradaxa (Dabigatran Etexilate) Products.

Before POSNER, SYKES, and HAMILTON, Circuit Judges.

POSNER, Circuit Judge.

Pradaxa is a prescription blood-thinning drug manufactured by an American company and its German affiliate (collectively Boehringer). A number of suits against Boehringer complaining about the accuracy of the warning label on the drug have been consolidated in the Southern District of Illinois for pretrial proceedings. The litigation is in the discovery stage. On December 9 of the just-ended year, the district judge presiding over the litigation...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases